These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 27495772

  • 1. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV, Flint SM, Shen A, Landgren A, Finlay M, Murugasu A, Masterson R, Hughes P, Cohney SJ.
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [Abstract] [Full Text] [Related]

  • 2. ABO-incompatible pediatric kidney transplantation without antibody removal.
    Kawamura T, Hamasaki Y, Takahashi Y, Hashimoto J, Kubota M, Muramatu M, Itabashi Y, Hyodo Y, Ohashi Y, Aikawa A, Sakai K, Shishido S.
    Pediatr Nephrol; 2020 Jan; 35(1):95-102. PubMed ID: 31673829
    [Abstract] [Full Text] [Related]

  • 3. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A, Oppenheimer F, Solé M, Revuelta I, Cid J, Lozano M, Blasco M, Esforzado N, Ricart MJ, Cofán F, Torregrosa JV, Paredes D, Musquera M, Ercilla G, Campistol JM, Diekmann F.
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry.
    Hattori M, Mieno M, Shishido S, Aikawa A, Ushigome H, Ohshima S, Takahashi K, Hasegawa A, Japan Society for Transplantation and Japanese Society for Clinical Renal Transplantation.
    Transplantation; 2018 Nov; 102(11):1934-1942. PubMed ID: 29781948
    [Abstract] [Full Text] [Related]

  • 5. Potent immunosuppression for ABO-incompatible renal transplantation may not be a risk factor for malignancy.
    Yamamoto T, Kawaguchi T, Watarai Y, Tujita M, Hiramitsu T, Nanmoku K, Goto N, Katayama A, Kobayashi T, Uchida K.
    Transplant Proc; 2012 Jan; 44(1):210-3. PubMed ID: 22310616
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of 2 Doses of Rituximab on B-Cell and Antidonor Antibody and Outcomes of ABO-Incompatible Living-Donor Pediatric Kidney Transplant.
    Hamasaki Y, Aikawa A, Itabashi Y, Muramatsu M, Hyoudou Y, Shinoda K, Takahashi Y, Sakurabayashi K, Mizutani T, Oguchi H, Kawamura T, Sakai K, Shishido S.
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):105-109. PubMed ID: 30777532
    [Abstract] [Full Text] [Related]

  • 7. Histological Analysis in ABO-Compatible and ABO-Incompatible Kidney Transplantation by Performance of 3- and 12-Month Protocol Biopsies.
    Masutani K, Tsuchimoto A, Kurihara K, Okabe Y, Kitada H, Okumi M, Tanabe K, Nakamura M, Kitazono T, Tsuruya K, Japan Academic Consortium of Kidney Transplantation (JACK) investigators.
    Transplantation; 2017 Jun; 101(6):1416-1422. PubMed ID: 27391195
    [Abstract] [Full Text] [Related]

  • 8. Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
    Hamano I, Hatakeyama S, Fujita T, Murakami R, Hamaya T, Togashi K, Suzuki Y, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Narumi S, Tomita H, Ohyama C.
    Transplant Proc; 2020 Jun; 52(6):1700-1704. PubMed ID: 32448659
    [Abstract] [Full Text] [Related]

  • 9. Preconditioning Therapy in ABO-Incompatible Living Kidney Transplantation: A Systematic Review and Meta-Analysis.
    Lo P, Sharma A, Craig JC, Wyburn K, Lim W, Chapman JR, Palmer SC, Strippoli GF, Wong G.
    Transplantation; 2016 Apr; 100(4):933-42. PubMed ID: 26425876
    [Abstract] [Full Text] [Related]

  • 10. Acute Rejection and Infectious Complications in ABO- and HLA-Incompatible Kidney Transplantations.
    Ko Y, Kim JY, Kim SH, Kim DH, Lim SJ, Shin S, Kim YH, Jung JH, Park SK, Kwon H, Han DJ.
    Ann Transplant; 2020 Oct 06; 25():e927420. PubMed ID: 33020465
    [Abstract] [Full Text] [Related]

  • 11. Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific Immunoadsorption.
    Becker LE, Siebert D, Süsal C, Opelz G, Leo A, Waldherr R, Macher-Goeppinger S, Schemmer P, Schaefer SM, Klein K, Beimler J, Zeier M, Schwenger V, Morath C.
    Transplantation; 2015 Nov 06; 99(11):2364-71. PubMed ID: 25989497
    [Abstract] [Full Text] [Related]

  • 12. ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone.
    Masterson R, Hughes P, Walker RG, Hogan C, Haeusler M, Robertson AR, Millar R, Suh N, Cohney SJ.
    Am J Transplant; 2014 Dec 06; 14(12):2807-13. PubMed ID: 25389083
    [Abstract] [Full Text] [Related]

  • 13. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S, Watarai Y, Yamamoto T, Hiramitsu T, Tsujita M, Nanmoku K, Goto N, Takeda A, Katayama A, Uchida K, Kobayashi T.
    Kidney Int; 2014 Feb 06; 85(2):425-30. PubMed ID: 23945498
    [Abstract] [Full Text] [Related]

  • 14. ABO incompatible kidney transplantation: the Saudi experience.
    Ali T, Broering D, Aleid H, Brockmann J, Alhumaidan H, Hammad E, Shah Y, Elgamal H, Alahmadi I, Hussein M, Raza S, Alabassi A, Ibrahim I, Shoukri M, Almeshari K.
    Saudi J Kidney Dis Transpl; 2019 Feb 06; 30(3):655-662. PubMed ID: 31249230
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcomes of ABO-incompatible kidney transplant with rituximab and double-filtration plasmapheresis.
    Han S, Hwang E, Park S, Park U, Kim H, Cho W.
    Exp Clin Transplant; 2014 Oct 06; 12(5):401-4. PubMed ID: 25299367
    [Abstract] [Full Text] [Related]

  • 16. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB, Orandi BJ, Waldram MM, Luo X, Nguyen AQ, Montgomery RA, Lentine KL, Segev DL.
    Am J Kidney Dis; 2020 Nov 06; 76(5):616-623. PubMed ID: 32668318
    [Abstract] [Full Text] [Related]

  • 17. Successful launch of an ABO-incompatible kidney transplantation program to overcome the shortage of compatible living donors: experience at a single center
.
    Song SH, Lee J, Kim BS, Kim S, Lee JG, Jeong HJ, Kim YS, Kim MS, Kim HO, Kim SI, Huh KH.
    Clin Nephrol; 2017 Sep 06; 88(9):117-123. PubMed ID: 28679466
    [Abstract] [Full Text] [Related]

  • 18. Individualized Preconditioning for ABO-Incompatible Living-Donor Kidney Transplantation: An Initial Report of 48 Cases from China.
    Wang XD, Liu JP, Fan Y, Song TR, Shi YY, Li YM, Lv YH, Li XH, Huang ZL, Lin T.
    Ann Transplant; 2020 Feb 07; 25():e920224. PubMed ID: 32029699
    [Abstract] [Full Text] [Related]

  • 19. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
    Hatakeyama S, Fujita T, Murakami R, Suzuki Y, Sugiyama N, Yamamoto H, Okamoto A, Imai A, Tobisawa Y, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Koie T, Narumi S, Ohyama C.
    Transplant Proc; 2014 Feb 07; 46(2):445-8. PubMed ID: 24655984
    [Abstract] [Full Text] [Related]

  • 20. One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.
    Dörje C, Mjøen G, Strøm EH, Holdaas H, Jenssen T, Øyen O, Akkök ÇA, Cvancarova M, Midtvedt K, Reisaeter AV.
    Clin Transplant; 2015 Mar 07; 29(3):268-76. PubMed ID: 25644963
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.